oasis-4 semaglutide 50 mg of oral #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj The first GLP-1 weight-loss pill:

Qeadan et al., 2025)

If youve tried other weight loss methods without successor youre ready to take your first major step toward healthier livingsemaglutide might be the supportive strategy you need

N la fentermina n lassociazione fentermina/topiramato sono disponibili, e non per una semplice mancata registrazione: la fentermina classificata come sostanza stupefacente in Tabella I del Testo unico sugli stupefacenti (DPR 309/90), la tabella che raccoglie le sostanze con maggiore potenziale dabuso

For people with T2D, survodutide 1.8 mg twice weekly resulted in 9% WL vs

The medication can potentially worsen kidney function, particularly in people who become dehydrated from gastrointestinal side effects like nausea, vomiting, or diarrhea

[DOI] [Google Scholar] 23.Pujadas G., Baggio L